Development of a novel human immunodeficiency virus type 1 subtyping tool, subtype analyzer (STAR): Analysis of subtype distribution in London

AIDS Research and Human Retroviruses

Volumn 20, Issue 5, 2004, Pages 457-464

  Gale, Catherine V ^a   Myers, Richard ^a   Tedder, Richard S ^a   Williams, Ian G ^a   Kellam, Paul ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE; RNA DIRECTED DNA POLYMERASE;

ACCURACY; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; DATA BASE; DERIVATIZATION; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS 1; MATHEMATICAL COMPUTING; MEDICAL ASSESSMENT; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SCORING SYSTEM; SEQUENCE ANALYSIS; TECHNIQUE; UNITED KINGDOM; VIRUS DETECTION; VIRUS GENE;

EID: 2642513126     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922204323087697     Document Type: Article

References (21)

1. Robertson DL, Anderson JP, Bradac JA, Carr JK, Foley B, Funkhouser RK, Gao F, Hahn BH, Kalish ML, Kuiken C, Learn GH Leitner T, McCutchan F, Osmanov S, Peeters M, Pieniazek D, Salminen M, Sharp PM, Wolinsky S, and Korber B: HIV-1 nomenclature proposal. Science 2000;288(5463):55-56.
2. Thomson MM, Perez-Alvarez L, and Najera R: Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect Dis 2002;2(8):461-471.
3. Apetrei C, Descamps D, Collin G, Loussert-Ajaka I, Damond F, Duca M, Simon F, and Brun-Vezinet F: Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility. J Virol 1998;72(5):3534-3538.
4. Descamps D, Apetrei C, Collin G, Damond F, Simon F, and Brun-Vezinet F: Naturally occurring decreased susceptibility of HIV-1 subtype G to protease inhibitors. AIDS 1998;12(9):1109-1111.
5. Descamps D, Collin G, Letourneur F, Apetrei C, Damond F, Loussert-Ajaka I, Simon F, Saragosti S, and Brun-Vezinet F: Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: In vitro phenotypic and genotypic analyses. J Virol 1997;71(11):8893-8898.
6. Apetrei C, Loussert-Ajaka I, Descamps D, Damond F, Saragosti S, Brun-Vezinet F, and Simon F: Lack of screening test sensitivity during HIV-1 non-subtype B seroconversions. AIDS 1996;10(14): F57-60.
7. Loussert-Ajaka I, Ly TD, Chaix ML, Ingrand D, Saragosti S, Courouce AM, Brun-Vezinet F, and Simon F: HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet 1994; 343(8910):1393-1394.
8. Parekh B, Phillips S Granade TC, Baggs J, Hu DJ, and Respess R: Impact of HIV type 1 subtype variation on viral RNA quantitation. AIDS Res Hum Retroviruses 1999;15(2):133-142.
9. van der Groen G, Nyambi PN, Beirnaert E, Davis D, Fransen K, Heyndrickx L, Ondoa P, Van der Auwera G, and Janssens W: Genetic variation of HIV type 1: Relevance of interclade variation to vaccine development. AIDS Res Hum Retroviruses 1998;14(Suppl. 3):S211-221.
10. Parry JV, Murphy G, Barlow KL, Lewis K, Rogers PA, Belda FJ, Nicoll A, McGarrigle C, Cliffe S, Mortimer PP, and Clewley JP: National surveillance of HIV-1 subtypes for England and Wales: Design, methods, and initial findings. J Acquir Immune Defic Syndr 2001;26(4):381-388.
11. Snoeck J, Van Dooren S, Van Laethem K, Derdelinckx I, Van Wijngaerden E, De Clercq E, and Vandamme AM: Prevalence and origin of HIV-1 group M subtypes among patients attending a Belgian hospital in 1999. Virus Res 2002;85(1):95-107.
12. Pasquier C, Millot N, Njouom R, Sandres K, Cazabat M, Puel J, and Izopet J: HIV-1 subtyping using phylogenetic analysis of pol gene sequences. J Virol Methods 2001;94(1-2):45-54.
13. Balotta C, Facchi G, Violin M, Van Dooren S, Cozzi-Lepri A, Forbici F, Bertoli A, Riva C, Senese D, Caramello P, Carnevale G, Rizzardini G, Cremonini L, Monno L, Rezza G, Perno CF, Ippolito G, d'Arminio-Monforte A, Vandamme AM, and Moroni M: Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences. J Acquir Immune Defic Syndr 2001;27 (5):499-505.
14. Becker-Pergola G, Kataaha P, Johnston-Dow L, Fung S, Jackson JB, and Eshleman SH: Analysis of HIV type 1 protease and reverse transcriptase in antiretroviral drug-naive Ugandan adults. AIDS Res Hum Retroviruses 2000;16(8):807-813.
15. Delgado E, Leon-Ponte M, Villahermosa ML, Cuevas MT, Deibis L, Echeverria G, Thomson MM, Perez-Alvarez L, Osmanov S, and Najera R: Analysis of HIV type 1 protease and reverse transcriptase sequences from Venezuela for drug resistance-associated mutations and subtype classification: A UNAIDS study. AIDS Res Hum Retroviruses 2001;17(8):753-758.
16. Vergne L, Peeters M, Mpoudi-Ngole E, Bourgeois A, Liegeois F, Toure-Kane C, Mboup S, Mulanga-Kabeya C, Saman E, Jourdan J, Reynes J, and Delaporte E: Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: Evidence of many minor drug resistance mutations in treatment-naive patients. J Clin Microbiol 2000;38(11):3919-3925.
17. Gonzales MJ, Machekano RN, and Shafer RW: Human immunodeficiency virus type 1 reverse-transcriptase and protease subtypes: Classification, amino acid mutation patterns, and prevalence in a northern California clinic-based population. J Infect Dis 2001;184(8):998-1006.
18. Hirsch MS, Brun-Vezinet F, D'Aquila RT, Hammer SM, Johnson VA, Kuritzkes DR, Loveday C, Mellors JW, Clotet B, Conway B, Demeter LM, Vella S, Jacobsen DM, and Richman DD: Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an International AIDS Society-USA Panel. JAMA 2000;283(18):2417-2426.
19. Miller V: European guidelines on resistance testing: Why are they needed? HIV Med 2000;1(3):129-131.
20. Van der Auwera G, Janssens W, Heyndrickx L, and van der Groen G: Reanalysis of full-length HIV type 1 group M subtype K and sub-subtype F2 with an MS-DOS bootscanning program. AIDS Res Hum Retroviruses 2001;17(2):185-189.
21. Liitsola K, Tashkinova I, Laukkanen T, Korovina G, Smolskaja T, Momot O, Mashkilleyson N, Chaplinskas S, Brummer-Korvenkontio H, Vanhatalo J, Leinikki P, and Salminen MO: HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad. AIDS 1998;12 (14):1907-1919.